RxDoctor Payments DataLook up a doctor →

Colleen Johnson

Adult Health · Akron, OHNPI 1932490083

Payments from drug & device makers

$17,291in general payments, 2019–2025

Across 849 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Jazz Pharmaceuticals Inc.$1K
  • UCB, Inc.$967
  • SK Life Science, Inc.$879
  • Neurocrine Biosciences, Inc.$857
  • plus $11K from 53 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie112$1,733
AstraZeneca49$1,232
Jazz Pharmaceuticals Inc.43$1,100
UCB, Inc.39$967
SK Life Science, Inc.44$879
Neurocrine Biosciences, Inc.45$857
Harmony Biosciences LLC36$709
Novartis50$702
Genentech USA, Inc.41$648
Biogen38$624
EMD Serono, Inc.26$576
Amgen(2 entities)25$549
Sanofi10$498
Teva Pharmaceuticals USA, Inc.29$479
Eisai Inc.15$472
Lundbeck LLC20$443
Inspire Medical Systems, Inc.4$415
Pfizer25$375
Biohaven Pharmaceuticals, Inc.7$333
Axsome Therapeutics, Inc.13$282
Impel Pharmaceuticals Inc.19$280
Octapharma USA, Inc.8$234
TG Therapeutics, Inc.9$211
Johnson & Johnson8$186
Lilly USA, LLC10$183
Acadia Pharmaceuticals Inc9$178
Argenx US, Inc.7$174
Sunovion Pharmaceuticals Inc.11$148
Otsuka America Pharmaceutical, Inc.6$136
Alnylam Pharmaceuticals Inc.1$122
Azurity Pharmaceuticals, Inc.8$121
Neurelis, Inc.7$120
Supernus Pharmaceuticals, Inc.5$112
E.r. Squibb & Sons, L.L.C.1$111
Biohaven Pharmaceutical Holding Company Ltd.4$90
Avanir Pharmaceuticals, Inc.5$89
Impel Pharmaceuticals LLC5$80
Almatica Pharma LLC6$79
Xeris Pharmaceuticals, Inc.6$78
Bristol Myers Squibb4$64
Catalyst Pharmaceuticals, Inc.3$60
Avion Pharmaceuticals3$58
Sumitomo Pharma America, Inc.6$57
CSL Behring3$51
Idorsia Pharmaceuticals US Inc3$45
Avadel CNS Pharmaceuticals, LLC2$44
Abbott2$39
Vanda Pharmaceuticals Inc.2$34
GE HealthCare4$32
Kyowa Kirin, Inc.2$31
Mallinckrodt Hospital Products Inc.1$29
Nevro Corp.1$23
Amneal Pharmaceuticals LLC1$20
Takeda Pharmaceuticals U.S.A., Inc.1$20
Banner Life Sciences, LLC1$19
Tanabe Pharma America, Inc.1$17
Collegium Pharmaceutical, Inc.1$16
Acorda Therapeutics, Inc1$14
Arbor Pharmaceuticals, Inc.1$14

How this compares

$17,291 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio →

Medicare billing

Part B allowed, 2024
$31,719
Medicare patients
289
Services billed
428

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Akron

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →